Illumina to buy Solexa for $600M

Illumina has agreed to buy Solexa, which makes genetics analysis systems, for $600 million. Illumina will also provide $50 million for Solexa, which specializes in whole genome sequencing. Illumina says it will maintain Solexa's operations in California and Cambridge, England. Solexa CEO John West becomes a senior vice president in the combined life science research firm.

- here's the report on the buyout from MarketWatch